LHRH (1-5) (free acid) is a peptide fragment corresponding to the N-terminal pentapeptide sequence of luteinizing hormone-releasing hormone. It is used as a pharmaceutical intermediate in the manufacture of peptide-based active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 52434-75-0
Dalareline
pharmaceutical raw material
(5alpha)-4,5-Epoxy-3,14-dihydroxymorphinan-6-one hydrochloride
pharmaceutical raw material
Flunarizine
pharmaceutical raw material
Buprenorphine
pharmaceutical raw material
Gonadorelin acetate impurity C
pharmaceutical raw material
(2S)-2-[[(2S)-3-hydroxy-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid
VVBDLEHCIKUJSA-XLIKFSOKSA-N
C1CC(=O)N[C@@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CC=C(C=C5)O)C(=O)O